Bill Text: TX SB1646 | 2019-2020 | 86th Legislature | Introduced


Bill Title: Relating to the controlled substances listed in Penalty Groups 1, 2, and 2-A under the Texas Controlled Substances Act.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2019-03-14 - Referred to Criminal Justice [SB1646 Detail]

Download: Texas-2019-SB1646-Introduced.html
  86R12665 JSC-F
 
  By: Miles S.B. No. 1646
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the controlled substances listed in Penalty Groups 1,
  2, and 2-A under the Texas Controlled Substances Act.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.102, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.102.  PENALTY GROUP 1.   Penalty Group 1 consists
  of:
               (1)  the following opiates, including their isomers,
  esters, ethers, salts, and salts of isomers, esters, and ethers,
  unless specifically excepted, if the existence of these isomers,
  esters, ethers, and salts is possible within the specific chemical
  designation:
                     Alfentanil;
                     Allylprodine;
                     Alphacetylmethadol;
                     Benzethidine;
                     Betaprodine;
                     Clonitazene;
                     Diampromide;
                     Diethylthiambutene;
                     Difenoxin not listed in Penalty Group 3 or 4;
                     Dimenoxadol;
                     Dimethylthiambutene;
                     Dioxaphetyl butyrate;
                     Dipipanone;
                     Ethylmethylthiambutene;
                     Etonitazene;
                     Etoxeridine;
                     Furethidine;
                     Hydroxypethidine;
                     Ketobemidone;
                     Levophenacylmorphan;
                     Meprodine;
                     Methadol;
                     Moramide;
                     Morpheridine;
                     Noracymethadol;
                     Norlevorphanol;
                     Normethadone;
                     Norpipanone;
                     Phenadoxone;
                     Phenampromide;
                     Phenomorphan;
                     Phenoperidine;
                     Piritramide;
                     Proheptazine;
                     Properidine;
                     Propiram;
                     Sufentanil;
                     Tilidine; and
                     Trimeperidine;
               (2)  the following opium derivatives, their salts,
  isomers, and salts of isomers, unless specifically excepted, if the
  existence of these salts, isomers, and salts of isomers is possible
  within the specific chemical designation:
                     Acetorphine;
                     Acetyldihydrocodeine;
                     Benzylmorphine;
                     Codeine methylbromide;
                     Codeine-N-Oxide;
                     Cyprenorphine;
                     Desomorphine;
                     Dihydromorphine;
                     Drotebanol;
                     Etorphine, except hydrochloride salt;
                     Heroin;
                     Hydromorphinol;
                     Methyldesorphine;
                     Methyldihydromorphine;
                     Monoacetylmorphine;
                     Morphine methylbromide;
                     Morphine methylsulfonate;
                     Morphine-N-Oxide;
                     Myrophine;
                     Nicocodeine;
                     Nicomorphine;
                     Normorphine;
                     Pholcodine; and
                     Thebacon;
               (3)  the following substances, however produced,
  except those narcotic drugs listed in another group:
                     (A)  Opium and opiate not listed in Penalty Group
  3 or 4, and a salt, compound, derivative, or preparation of opium or
  opiate, other than thebaine derived butorphanol, nalmefene and its
  salts, naloxone and its salts, and naltrexone and its salts, but
  including:
                           Codeine not listed in Penalty Group 3 or 4;
                           Dihydroetorphine;
                           Ethylmorphine not listed in Penalty Group 3
  or 4;
                           Granulated opium;
                           Hydrocodone not listed in Penalty Group 3;
                           Hydromorphone;
                           Metopon;
                           Morphine not listed in Penalty Group 3;
                           Opium extracts;
                           Opium fluid extracts;
                           Oripavine;
                           Oxycodone;
                           Oxymorphone;
                           Powdered opium;
                           Raw opium;
                           Thebaine; and
                           Tincture of opium;
                     (B)  a salt, compound, isomer, derivative, or
  preparation of a substance that is chemically equivalent or
  identical to a substance described by Paragraph (A), other than the
  isoquinoline alkaloids of opium;
                     (C)  Opium poppy and poppy straw;
                     (D)  Cocaine, including:
                           (i)  its salts, its optical, position, and
  geometric isomers, and the salts of those isomers;
                           (ii)  coca leaves and a salt, compound,
  derivative, or preparation of coca leaves; and
                           (iii)  a salt, compound, derivative, or
  preparation of a salt, compound, or derivative that is chemically
  equivalent or identical to a substance described by Subparagraph
  (i) or (ii), other than decocainized coca leaves or extractions of
  coca leaves that do not contain cocaine or ecgonine; and
                     (E)  concentrate of poppy straw, meaning the crude
  extract of poppy straw in liquid, solid, or powder form that
  contains the phenanthrine alkaloids of the opium poppy;
               (4)  the following opiates and opioids, including their
  isomers, esters, ethers, salts, and salts of isomers, if the
  existence of these isomers, esters, ethers, and salts is possible
  within the specific chemical designation:
                     (A)  [Acetyl-alpha-methylfentanyl
  (N-[1-(1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide);
                     [Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
  thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);]
                     Alphaprodine;
                     Anileridine;
                     [Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
  phenethyl)-4-piperidinyl] -N-phenylpropanamide);
                     [Beta-hydroxy-3-methylfentanyl;]
                     Bezitramide;
                     [Carfentanil;]
                     Dihydrocodeine not listed in Penalty Group 3 or 4;
                     Diphenoxylate not listed in Penalty Group 3 or 4;
                     Fentanyl [or alpha-methylfentanyl, or any other
  derivative of Fentanyl];
                     Isomethadone;
                     Levomethorphan;
                     Levorphanol;
                     Metazocine;
                     Methadone;
                     Methadone-Intermediate, 4-cyano-2-dimethylamino-
  4, 4-diphenyl butane;
                     [3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
  4-piperidyl]-N-phenylpropanamide);
                     [3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
  ethyl-4-piperidinyl]-N-phenylpropanamide);]
                     Moramide-Intermediate, 2-methyl-3-morpholino-1,
  1-diphenyl-propane-carboxylic acid;
                     Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
  phenylethyl)-4-piperidinylpropanamide);
                     PEPAP (1-(2-phenethyl)-4-phenyl-4-
  acetoxypiperidine);
                     Pethidine (Meperidine);
                     Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
  phenylpiperidine;
                     Pethidine-Intermediate-B, ethyl-4-
  phenylpiperidine-4 carboxylate;
                     Pethidine-Intermediate-C, 1-methyl-4-
  phenylpiperidine-4-carboxylic acid;
                     Phenazocine;
                     Piminodine;
                     Racemethorphan; and
                     Racemorphan[;
                     [Remifentanil; and
                     [Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-
  piperidinyl]-propanamide)]; and
                     (B)  a substance related to fentanyl, unless
  specifically excepted or controlled in another Penalty Group,
  including any substance that is structurally related to fentanyl by
  one or more of the following modifications:
                           (i)  substitution on or replacement of the
  phenethyl group, such as:
                                 Alpha methyl fentanyl;
                                 Benzyl fentanyl; and
                                 Thionyl fentanyl (HCl);
                           (ii)  substitution on the piperidine ring,
  such as:
                                 Carfentanil;
                                 3-Fluorofentanyl (HCl); and
                                 4-Phenyl fentanyl (HCl);
                           (iii)  substitution on the aniline ring,
  such as:
                                 para-Fluorofentanyl;
                                 meta-Fluorofentanyl; and
                                 ortho-Fluorofentanyl; and
                           (iv)  substitution or replacement of the
  N-propionyl group, such as:
                                 Acetyl fentanyl (HCL);
                                 Benzodioxole fentanyl; and
                                 Furanyl fentanyl (HCl);
               (5)  Flunitrazepam (trade or other name: Rohypnol);
               (6)  Methamphetamine, including its salts, optical
  isomers, and salts of optical isomers;
               (7)  Phenylacetone and methylamine, if possessed
  together with intent to manufacture methamphetamine;
               (8)  Phencyclidine, including its salts;
               (9)  Gamma hydroxybutyric acid (some trade or other
  names: gamma hydroxybutyrate, GHB), including its salts;
               (10)  Ketamine;
               (11)  Phenazepam;
               (12)  U-47700;
               (13)  AH-7921;
               (14)  ADB-FUBINACA;
               (15)  AMB-FUBINACA; and
               (16)  MDMB-CHMICA.
         SECTION 2.  Section 481.103(a), Health and Safety Code, is
  amended to read as follows:
         (a)  Penalty Group 2 consists of:
               (1)  any quantity of the following hallucinogenic
  substances, their salts, isomers, and salts of isomers, unless
  specifically excepted, if the existence of these salts, isomers,
  and salts of isomers is possible within the specific chemical
  designation:
                     5-(2-aminopropyl)benzofuran (5-APB);
                     6-(2-aminopropyl)benzofuran (6-APB);
                     5-(2-aminopropyl)-2,3-dihydrobenzofuran
  (5-APDB);
                     6-(2-aminopropyl)-2,3-dihydrobenzofuran
  (6-APDB);
                     5-(2-aminopropyl)indole (5-IT,5-API);
                     6-(2-aminopropyl)indole (6-IT,6-API);
                     1-(benzofuran-5-yl)-N-methylpropan-2-amine
  (5-MAPB);
                     1-(benzofuran-6-yl)-N-methylpropan-2-amine
  (6-MAPB);
                     Benzothiophenylcyclohexylpiperidine (BTCP);
                     8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
  4-ethanamine (trade or other name: Bromo-DragonFLY);
                     Desoxypipradrol (2-benzhydrylpiperidine);
                     2, 5-dimethoxyamphetamine (some trade or other
  names:  2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
                     Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
  methanol, D2PM);
                     Dronabinol (synthetic) in sesame oil and
  encapsulated in a soft gelatin capsule in a U.S. Food and Drug
  Administration approved drug product (some trade or other names for
  Dronabinol:  (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
  trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
  (trans)- tetrahydrocannabinol);
                     Ethylamine Analog of Phencyclidine (some trade or
  other names:  N-ethyl-1-phenylcyclohexylamine, (1-
  phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
  cyclohexamine, PCE);
                     2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
  (trade or other name: methoxetamine);
                     Ibogaine (some trade or other names:  7-Ethyl-6,
  6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
  pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
                     5-iodo-2-aminoindane (5-IAI);
                     Mescaline;
                     5-methoxy-3, 4-methylenedioxy amphetamine;
                     4-methoxyamphetamine (some trade or other
  names:  4-methoxy-alpha-methylphenethylamine;
  paramethoxyamphetamine; PMA);
                     4-methoxymethamphetamine (PMMA);
                     2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
  (some trade and other names: 2-MeO-ketamine; methoxyketamine);
                     1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
  PPMP);
                     4-methyl-2, 5-dimethoxyamphetamine (some trade
  and other names:  4-methyl-2, 5-dimethoxy-alpha-
  methylphenethylamine; "DOM"; "STP");
                     3,4-methylenedioxy methamphetamine (MDMA, MDM);
                     3,4-methylenedioxy amphetamine;
                     3,4-methylenedioxy N-ethylamphetamine (Also
  known as N-ethyl MDA);
                     5,6-methylenedioxy-2-aminoindane (MDAI);
                     Nabilone (Another name for nabilone:  (+)-trans-
  3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
  6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
                     N-benzylpiperazine (some trade or other
  names:  BZP; 1-benzylpiperazine);
                     N-ethyl-3-piperidyl benzilate;
                     N-hydroxy-3,4-methylenedioxyamphetamine (Also
  known as N-hydroxy MDA);
                     4-methylaminorex;
                     N-methyl-3-piperidyl benzilate;
                     Parahexyl (some trade or other names:  3-Hexyl-1-
  hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
  pyran; Synhexyl);
                     1-Phenylcyclohexylamine;
                     1-Piperidinocyclohexanecarbonitrile (PCC);
                     Pyrrolidine Analog of Phencyclidine (some trade
  or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
                     Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure,
  [and pharmacological activity] such as:
                           delta-9-tetrahydrocannabinolic acid (some
  trade name or other name: THCA-A and THCA-B);
                           delta-9-tetrahydrocannabinol, and its
  optical isomers;
                           delta-1 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-6 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-3, 4 cis or trans
  tetrahydrocannabinol, and its optical isomers; or
                           compounds of these structures, regardless of
  numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized;
                     Thiophene Analog of Phencyclidine (some trade or
  other names:  1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
  Analog of Phencyclidine; TPCP, TCP);
                     1-pyrrolidine (some trade or other name:  TCPy);
                     1-(3-trifluoromethylphenyl)piperazine (trade or
  other name:  TFMPP); and
                     3,4,5-trimethoxy amphetamine;
               (2)  Phenylacetone (some trade or other
  names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
  ketone);
               (3)  unless specifically excepted or unless listed in
  another Penalty Group, a material, compound, mixture, or
  preparation that contains any quantity of the following substances
  having a potential for abuse associated with a depressant or
  stimulant effect on the central nervous system:
                     Aminorex (some trade or other
  names:  aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
  phenyl-2-oxazolamine);
                     Amphetamine, its salts, optical isomers, and
  salts of optical isomers;
                     Cathinone (some trade or other names:  2-amino-1-
  phenyl-1-propanone, alpha-aminopropiophenone, 2-
  aminopropiophenone);
                     Etaqualone and its salts;
                     Etorphine Hydrochloride;
                     Fenethylline and its salts;
                     Lisdexamfetamine, including its salts, isomers,
  and salts of isomers;
                     Mecloqualone and its salts;
                     Methaqualone and its salts;
                     Methcathinone (some trade or other names:  2-
  methylamino-propiophenone; alpha-(methylamino)propriophenone;
  2-(methylamino)-1-phenylpropan-1-one; alpha-N-
  methylaminopropriophenone; monomethylpropion; ephedrone, N-
  methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
  1431);
                     N-Ethylamphetamine, its salts, optical isomers,
  and salts of optical isomers; and
                     N,N-dimethylamphetamine (some trade or other
  names: N,N,alpha-trimethylbenzeneethanamine;
  N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
  and salts of optical isomers;
               (4)  any compound structurally derived from
  2-aminopropanal by substitution at the 1-position with any
  monocyclic or fused-polycyclic ring system, including:
                     (A)  compounds further modified by:
                           (i)  substitution in the ring system to any
  extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
  halide substituents), whether or not further substituted in the
  ring system by other substituents;
                           (ii)  substitution at the 3-position with an
  alkyl substituent; or
                           (iii)  substitution at the 2-amino nitrogen
  atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or
  inclusion of the 2-amino nitrogen atom in a cyclic structure; and
                     (B)  by example, compounds such as:
                           4-Methylmethcathinone (Also known as
  Mephedrone);
                           3,4-Dimethylmethcathinone (Also known as
  3,4-DMMC);
                           3-Fluoromethcathinone (Also known as 3-FMC);
                           4-Fluoromethcathinone (Also known as
  Flephedrone);
                           3,4-Methylenedioxy-N-methylcathinone (Also
  known as Methylone);
                           3,4-Methylenedioxypyrovalerone (Also known
  as MDPV);
                           alpha-Pyrrolidinopentiophenone (Also known
  as alpha-PVP);
                           Naphthylpyrovalerone  (Also known as
  Naphyrone);
                           alpha-Methylamino-valerophenone (Also known
  as Pentedrone);
                           beta-Keto-N-methylbenzodioxolylpropylamine
  (Also known as Butylone);
                           beta-Keto-N-methylbenzodioxolylpentanamine
  (Also known as Pentylone);
                           beta-Keto-Ethylbenzodioxolylbutanamine
  (Also known as Eutylone); and
                           3,4-methylenedioxy-N-ethylcathinone (Also
  known as Ethylone);
               (5)  any compound structurally derived from tryptamine
  (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
                     (A)  by modification in any of the following ways:
                           (i)  by substitution at the amine nitrogen
  atom of the sidechain to any extent with alkyl or alkenyl groups or
  by inclusion of the amine nitrogen atom of the side chain (and no
  other atoms of the side chain) in a cyclic structure;
                           (ii)  by substitution at the carbon atom
  adjacent to the nitrogen atom of the side chain (alpha-position)
  with an alkyl or alkenyl group;
                           (iii)  by substitution in the 6-membered
  ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
  alkylenedioxy, or halide substituents; or
                           (iv)  by substitution at the 2-position of
  the tryptamine ring system with an alkyl substituent; and
                     (B)  including:
                           (i)  ethers and esters of the controlled
  substances listed in this subdivision; and
                           (ii)  by example, compounds such as:
                                 alpha-ethyltryptamine;
                                 alpha-methyltryptamine;
                                 Bufotenine (some trade and other names:
  3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
  3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
  5-hydroxy-N, N- dimethyltryptamine; mappine);
                                 Diethyltryptamine (some trade and
  other names: N, N-Diethyltryptamine, DET);
                                 Dimethyltryptamine (trade or other
  name: DMT);
                                 5-methoxy-N, N-diisopropyltryptamine
  (5-MeO-DiPT);
                                 O-Acetylpsilocin (Trade or other name:
  4-Aco-DMT);
                                 Psilocin; and
                                 Psilocybin;
               (6)  2,5-Dimethoxyphenethylamine and any compound
  structurally derived from 2,5-Dimethoxyphenethylamine by
  substitution at the 4-position of the phenyl ring to any extent
  (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
  substituents), including, by example, compounds such as:
                     4-Bromo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-B);
                     4-Chloro-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-C);
                     2,5-Dimethoxy-4-methylphenethylamine (trade or
  other name: 2C-D);
                     4-Ethyl-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-E);
                     4-Iodo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-I);
                     2,5-Dimethoxy-4-nitrophenethylamine (trade or
  other name: 2C-N);
                     2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
  or other name: 2C-P);
                     4-Ethylthio-2,5-dimethoxyphenethylamine (trade
  or other name: 2C-T-2);
                     4-Isopropylthio-2,5-dimethoxyphenethylamine
  (trade or other name: 2C-T-4); and
                     2,5-Dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name:  2C-T-7); and
               (7)  2,5-Dimethoxyamphetamine and any compound
  structurally derived from 2,5-Dimethoxyamphetamine by substitution
  at the 4-position of the phenyl ring to any extent (including alkyl,
  alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
  including, by example, compounds such as:
                     4-Ethylthio-2,5-dimethoxyamphetamine (trade or
  other name: Aleph-2);
                     4-Isopropylthio-2,5-dimethoxyamphetamine (trade
  or other name: Aleph-4);
                     4-Bromo-2,5-dimethoxyamphetamine (trade or other
  name: DOB);
                     4-Chloro-2,5-dimethoxyamphetamine (trade or
  other name: DOC);
                     2,5-Dimethoxy-4-ethylamphetamine (trade or other
  name: DOET);
                     4-Iodo-2,5-dimethoxyamphetamine (trade or other
  name: DOI);
                     2,5-Dimethoxy-4-methylamphetamine (trade or
  other name: DOM);
                     2,5-Dimethoxy-4-nitroamphetamine (trade or other
  name: DON);
                     4-Isopropyl-2,5-dimethoxyamphetamine (trade or
  other name: DOIP); and
                     2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
  other name: DOPR).
         SECTION 3.  Section 481.1031, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.1031.  PENALTY GROUP 2-A. (a)  In this section:
               (1)  "Core component" is one of the following:  
  azaindole, beta carboline, benzimidazole, benzothiazole,
  carbazole, gamma carboline, imidazole, indane, indazole, indene,
  indole, naphthalene, pyrazole, pyrazolopyridine, pyridine, or
  pyrrole.
               (2)  "Group A component" is one of the following:  
  adamantane, benzylpiperazine, benzyl, cumene [benzene],
  cycloalkylmethyl, cyclopropylmethyl, isoquinoline,
  methylpiperazine, naphthalene, pyrrolidine, phenyl, quinoline,
  tetrahydronaphthalene, tetramethylcyclopropane, amino oxobutane,
  amino methyl ovobutane, amino dimethyl oxobutane, amino phenyl
  oxopropane, amino oxopentane, ethoxy oxobutane, ethoxy methyl
  oxobutane, ethoxy dimethyl oxobutane, ethoxy phenyl oxopropane,
  ethoxy oxopentane, methoxy oxobutane, methoxy methyl oxobutane
  [methyl methoxy oxobutane], methoxy dimethyl oxobutane, methoxy
  phenyl oxopropane, methoxy oxopentane, or any substituted [an]
  amino acid.
               (3)  "Link component" is one of the following
  functional groups:  carboxamide, carboxylate, hydrazide,
  methanone (ketone), ethanone, methanediyl (methylene bridge), or
  methine.
         (b)  Penalty Group 2-A consists of any material, compound,
  mixture, or preparation that contains any quantity of a natural or
  synthetic chemical substance, including its salts, isomers, and
  salts of isomers, listed by name in this subsection or contained
  within one of the structural classes defined in this subsection:
               (1)  WIN-55,212-2;
               (2)  Cyclohexylphenol:  any compound structurally
  derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the
  5-position of the phenolic ring, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
  not substituted in the cyclohexyl ring to any extent, including:
                     JWH-337;
                     JWH-344;
                     CP-55,940;
                     CP-47,497; and
                     analogues of CP-47,497;
               (3)  Cannabinol derivatives, except where contained in
  marihuana, including tetrahydro derivatives of cannabinol and
  3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
  such as:
                     Nabilone;
                     HU-210; and
                     HU-211;
               (4)  Tetramethylcyclopropyl thiazole:  any compound
  structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-
  2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen
  atom of the thiazole ring, whether or not further substituted in the
  thiazole ring to any extent, whether or not substituted in the
  tetramethylcyclopropyl ring to any extent, such as [including]:
                     A-836,339;
               (5)  any compound containing a core component
  substituted at the 1-position to any extent, and substituted at the
  3-position with a link component attached to a group A component,
  whether or not the core component or group A component are further
  substituted to any extent, such as [including]:
                     Naphthoylindane;
                     Naphthoylindazole (THJ-018);
                     Naphthyl methyl indene (JWH-171);
                     Naphthoylindole (JWH-018);
                     Quinolinoyl pyrazole carboxylate (Quinolinyl
  fluoropentyl fluorophenyl pyrazole carboxylate);
                     Naphthoyl pyrazolopyridine; and
                     Naphthoylpyrrole (JWH-030);
               (6)  any compound containing a core component
  substituted at the 1-position to any extent, and substituted at the
  2-position with a link component attached to a group A component,
  whether or not the core component or group A component are further
  substituted to any extent, such as [including]:
                     Naphthoylbenzimidazole (JWH-018 Benzimidazole);
  and
                     Naphthoylimidazole;
               (7)  any compound containing a core component
  substituted at the 3-position to any extent, and substituted at the
  2-position with a link component attached to a group A component,
  whether or not the core component or group A component are further
  substituted to any extent, such as [including]:
                     Naphthoyl benzothiazole; [and]
               (8)  any compound containing a core component
  substituted at the 9-position to any extent, and substituted at the
  3-position with a link component attached to a group A component,
  whether or not the core component or group A component are further
  substituted to any extent, including:
                     Naphthoylcarbazole (EG-018); and
                     Synthetic chemical compounds with a carbazole
  core structure, regardless of numerical designation of atomic
  positions, since this core structure is symmetrical;
               (9)  any compound containing a core component
  substituted at the 1-position to any extent and substituted at the
  5-position with a link component attached to a group A component,
  regardless of whether the core component or group A component are
  further substituted to any extent, such as:
                     5-fluoro-3,5-ADB-PFUPPYCA (5f-AB-PFUPPYCA);
               (10)  any compound containing a core component
  substituted at the 2-position to any extent and substituted at the
  3-position with a link component attached to a group A component,
  regardless of whether the core component or group A component are
  further substituted to any extent, such as:
                     AB-CHMINACA (2H) indazole; and
               (11)  any compound containing a core component
  substituted at the 5-position to any extent and substituted at the
  2-position with a group A component, regardless of whether the core
  component or group A component are further substituted to any
  extent, such as:
                     Cumyl-PeGACLONE.
         (c)  In this section, a synthetic chemical substance
  analogue is:
               (1)  any substance, unless specifically excepted, that
  has two of the three components as defined by Subsection (a) and a
  numerical core-link position that is listed in Subsection (b)(5),
  (6), (7), (8), (9), or (10);
               (2)  any substance, unless specifically excepted, that
  has a core, link, and group A component as defined by Subsection (a)
  but does not have a numerical core-link position that is listed in
  Subsection (b)(5), (6), (7), (8), (9), or (10); or
               (3)  any substance, unless specifically excepted, that
  has a core component or group A component as defined by Subsection
  (a) and a numerical core-group A position that is listed in
  Subsection (b)(11).
         SECTION 4.  The change in law made by this Act applies only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense occurred
  before that date.
         SECTION 5.  This Act takes effect September 1, 2019.
feedback